AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed Apr 24, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 228
- +12 vs. Q4 2023
- Portfolio value
- $165.8M
- +$16.8M (+11.3%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RPRXRoyalty Pharma plc | SHS CLASS A | 60,000 | $1.82M | 1.1% | +20,000+50.0% | Added | History |
| RWTRedwood Trust Inc | COM | 288,343 | $1.84M | 1.1% | +141,750+96.7% | Added | History |
| MFAMfa Financial, Inc. | COM | 167,725 | $1.91M | 1.2% | +25,000+17.5% | Added | History |
| Pennymac Corp70932AAD5 | NOTE 5.500%11/0 | 1,965,000 | $1.94M | 1.2% | 00.0% | Unchanged | – |
| EXASExact Sciences Corp | COM | 29,000 | $2.00M | 1.2% | +29,000 | New | History |
| FOLDAmicus Therapeutics, Inc. | COM | 175,000 | $2.06M | 1.2% | +35,000+25.0% | Added | History |
| CATXPerspective Therapeutics, Inc. | COM | 1,756,756 | $2.09M | 1.3% | +1,756,756 | New | History |
| CORTCorcept Therapeutics Inc | COM | 85,000 | $2.14M | 1.3% | +85,000 | New | History |
| URGNUroGen Pharma Ltd. | COM | 143,898 | $2.16M | 1.3% | −11,102−7.2% | Reduced | History |
| DXDynex Capital Inc | COM | 181,492 | $2.26M | 1.4% | 00.0% | Unchanged | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 94,000 | $2.36M | 1.4% | +44,000+88.0% | Added | History |
| CHRSCoherus Oncology, Inc. | COM | 1,000,000 | $2.39M | 1.4% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 460,000 | $2.39M | 1.4% | +38,975+9.3% | Added | History |
| MTGMgic Investment Corp | COM | 114,379 | $2.56M | 1.5% | +35,000+44.1% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 32,500 | $2.59M | 1.6% | +32,500 | New | History |
| EFCEllington Financial Inc. | COM | 221,602 | $2.62M | 1.6% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 16,750 | $2.62M | 1.6% | +9,250+123.3% | Added | History |
| DCGODocGo Inc. | COM | 650,000 | $2.63M | 1.6% | +340,000+109.7% | Added | History |
| NARIInari Medical, Inc. | Stock | 63,000 | $3.02M | 1.8% | +58,000+1,160.0% | Added | History |
| Two HBRS Invt Corp90187BAB7 | NOTE 6.250% 1/1 | 3,205,000 | $3.04M | 1.8% | 00.0% | Unchanged | – |
| ARGXArgenx SE | SPONSORED ADR | 8,000 | $3.15M | 1.9% | +250+3.2% | Added | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 105,000 | $3.38M | 2.0% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 675,000 | $3.43M | 2.1% | 00.0% | Unchanged | History |
| PCRXPacira BioSciences, Inc. | COM | 117,500 | $3.43M | 2.1% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 16,000 | $3.68M | 2.2% | +16,000 | New | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 122,000 | $4.10M | 2.5% | 00.0% | Unchanged | History |
| RITMRithm Capital Corp. | REIT | 420,966 | $4.70M | 2.8% | +20,000+5.0% | Added | History |
| PFEPfizer Inc | Stock | 175,000 | $4.86M | 2.9% | +95,000+118.8% | Added | History |
Sold out since Q4 2023 (26)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| IMGNImmunoGen, Inc. | COM | 127,500 | $3.78M | 2.5% | History |
| WBAWalgreens Boots Alliance, Inc. | COM | 120,000 | $3.13M | 2.1% | History |
| ABVXAbivax S.A. | SPONSORED ADS | 267,500 | $2.86M | 1.9% | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 245,000 | $2.80M | 1.9% | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 151,000 | $2.22M | 1.5% | History |
| VSTMVerastem, Inc. | COM NEW | 150,000 | $1.22M | 0.8% | History |
| KRTXKaruna Therapeutics, Inc. | COM | 3,500 | $1.11M | 0.7% | History |
| MBLYMobileye Global Inc. | Stock | 20,000 | $866.4K | 0.6% | History |
| OMCLOmnicell, Inc. | COM | 20,000 | $752.6K | 0.5% | History |
| IRTCiRhythm Holdings, Inc. | COM | 5,000 | $535.2K | 0.4% | History |
| HOSHornbeck Offshore Services, Inc. | Stock | 50,000 | $514.0K | 0.3% | History |
| VTRSViatris Inc | Stock | 35,000 | $379.1K | 0.3% | History |
| DPRODraganfly Inc. | COM NEW | 500,000 | $239.8K | 0.2% | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 10,000 | $236.2K | 0.2% | History |
| MQYBlackRock Muniyield Quality Fund, Inc. | COM | 5,100 | $62.2K | <0.1% | History |
| MHDBlackRock Muniholdings Fund, Inc. | COM | 5,150 | $61.3K | <0.1% | History |
| MUCBlackRock Muniholdings California Quality Fund, Inc. | CEF | 5,500 | $61.2K | <0.1% | History |
| MUJBlackRock Muniholdings New Jersey Quality Fund, Inc. | COM | 5,350 | $61.0K | <0.1% | History |
| BLEBlackRock Municipal Income Trust II | COM | 5,700 | $60.9K | <0.1% | History |
| MUIBlackRock Municipal Credit Alpha Portfolio, Inc. | COM | 5,200 | $60.5K | <0.1% | History |
| NOTEFiscalNote Holdings, Inc. | COMMON STOCK | 50,000 | $57.0K | <0.1% | History |
| EIMEaton Vance Municipal Bond Fund | COM | 5,000 | $50.6K | <0.1% | History |
| NMCONuveen Municipal Credit Opportunities Fund | COM | 5,000 | $49.9K | <0.1% | History |
| NDMONuveen Dynamic Municipal Opportunities Fund | COM SHS | 5,000 | $49.5K | <0.1% | History |
| PMMFranklin Managed Municipal Income Trust | COM | 8,125 | $49.4K | <0.1% | History |
| iShares Inc464286640 | MSCI CHILE ETF | 662 | $18.7K | <0.1% | – |